CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L603. A total of 11 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $124 | -41.0% | 363,367 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $210 | +1.9% | 363,367 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $206 | -14.2% | 363,367 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $240 | -100.0% | 363,367 | -1.1% | 0.00% | -66.7% |
| Q3 2022 | $535,000 | +643.1% | 367,477 | +449.3% | 0.00% | – |
| Q2 2022 | $72,000 | +3500.0% | 66,900 | +8315.1% | 0.00% | – |
| Q1 2022 | $2,000 | -97.8% | 795 | -96.6% | 0.00% | – |
| Q4 2021 | $89,000 | +134.2% | 23,242 | +257.5% | 0.00% | – |
| Q2 2021 | $38,000 | -84.3% | 6,502 | -80.9% | 0.00% | -100.0% |
| Q1 2021 | $242,000 | +4.8% | 34,057 | -31.5% | 0.00% | 0.0% |
| Q2 2020 | $231,000 | – | 49,707 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 250,000 | $365,000 | 0.05% |
| McIlrath & Eck, LLC | 26,342 | $38,000 | 0.01% |
| Schonfeld Strategic Advisors LLC | 615,200 | $898,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 367,477 | $535,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 12,800 | $19,000 | 0.00% |
| Point72 Asset Management, L.P. | 230,000 | $336,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 61,816 | $90,000 | 0.00% |
| STATE STREET CORP | 10,510 | $15,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 195,445 | $285,000 | 0.00% |
| MORGAN STANLEY | 1,200 | $2,000 | 0.00% |